Growth Metrics

Moderna (MRNA) Debt to Equity (2025)

Moderna (MRNA) has disclosed Debt to Equity for 1 consecutive years, with $0.07 as the latest value for Q4 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $0.07 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.07, a N/A change, with the full-year FY2025 number at $0.07, changed N/A from a year prior.
  • Debt to Equity was $0.07 for Q4 2025 at Moderna.
  • In the past five years, Debt to Equity ranged from a high of $0.07 in Q4 2025 to a low of $0.07 in Q4 2025.